|
    ABCL U.S.: Nasdaq

    AbCellera Biologics Inc.

    ABCLUS
    After Hours
    Last Updated: Sep 17, 2021 7:59 p.m. EDT Delayed quote

    $ 20.06

    -0.30 -1.47%
    After Hours Volume: 173.41K
    Close Chg Chg %
    $20.36 0.56 2.83%
    Advanced Charting
    Volume: 14.64M 65 Day Avg: 2.4M
    610% vs Avg
    19.81 Day Range 22.63
    14.51 52 Week Range 71.91

    Your Watchlists

    Customize eLesor

    Have Watchlists? Log in to see them here or sign up to get started.

    Symbol
    Company
    Price
    Chg/Chg %
    No Items in Watchlist

    There are currently no items in this Watchlist.

    Uh oh

    Something went wrong while loading Watchlist.

    Recently Viewed Tickers

    No Recent Tickers

    Visit a quote page and your recently viewed tickers will be displayed here.

    ABCL Overview

    Performance

    5 Day
    • 7.21%
    1 Month
    • 26.93%
    3 Month
    • -12.20%
    YTD
    • -49.40%

    Analyst Ratings

    • Sell
    • Under
    • Hold
    • Over
    • Buy
    Number of Ratings 5 Full Ratings

    Recent News

    Read full story

    FDA’s Call on Lilly’s Covid Drug Is Lifting a Partner’s Beaten-Down Stock

    AbCellera Biologics in Research Licensing Deal With Moderna

    Read full story

    Biotech Is Due for a Comeback. 5 Stocks That Could Lead a Revival.

    Read full story

    Here Are the Best and Worst Biopharma Stock Performers So Far This Year

    Read full story

    Premarket Movers: AbCellera Biologics, Cincinnati Financial, Franklin Resources

    Read full story

    Premarket Movers: Plug Power, DoorDash, AbCellera Biologics

    Read full story

    Premarket Movers: ZoomInfo Tech, Alteryx Cl A, Caesars Entertainment

    Read full story

    Premarket Movers: GameStop Cl A, ChargePoint Holdings, Invitae

    Read full story

    CORRECTION: Premarket Movers

    Read full story

    Premarket Movers: QuantumScape, Discovery Series B, Insulet

    Read full story

    Premarket Movers: Chewy, Arrival, ChargePoint Holdings

    Read full story

    Premarket Movers: AbCellera Biologics, Sana Biotechnology, Virgin Galactic

    Read full story

    Premarket Movers: Quanta Services, AbCellera Biologics, DISH Network Cl A

    Read full story

    Premarket Movers: Coherent, Skillz, Sarepta Therapeutics

    Read full story

    Certara IPO Soars 66%. Employees Will Get Shares.

    Read full story

    AbCellera Rockets 195%, 4D Molecular Up 76% as Flurry of Health-Care IPOs Begin Trading

    AbCellera Biologics sets terms of IPO, which could value the company at up to $4.5 billion

    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

    on InvestorPlace.com

    FDA Extends EUA for AbCellera’s Bamlanivimab; Shares Rally 19.8%

    on TipRanks.com

    AbCellera Collaborates with Moderna; Shares Rise 7.1%

    on TipRanks.com

    Why AbCellera Biologics Stock Jumped 7% on Wednesday

    on Motley Fool

    Here's Why AbCellera Biologics Stock Gained 10.6% Last Month

    on Motley Fool

    Guardian Capital Advisors Lp Buys AbCellera Biologics Inc, Fortis Inc, Cleveland-Cliffs Inc, ...

    on GuruFocus.com

    Brandywine Managers, Llc Buys UiPath Inc, CrowdStrike Holdings Inc, , Sells DraftKings Inc, ...

    on GuruFocus.com

    Why AbCellera Biologics Stock Was Up More Than 17% on Friday

    on Motley Fool

    Analysts Are Bullish on These Healthcare Stocks: Armata Pharmaceuticals (ARMP), Corbus Pharmaceuticals (CRBP)

    on TipRanks.com

    AbCellera Biologics Inc. (ABCL) Q2 2021 Earnings Call Transcript

    on Motley Fool

    Is It Time to Buy 5 of the Nasdaq's Worst-Performing Stocks of 2021?

    on Motley Fool

    Interested in Investing in Canadian Stocks? Check This Out.

    on Motley Fool

    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

    on InvestorPlace.com

    AbCellera Biologics (ABCL) Received its Third Buy in a Row

    on SmarterAnalyst

    AbCellera Biologics Inc. (ABCL) Q1 2021 Earnings Call Transcript

    on Motley Fool

    Berenberg Bank Thinks AbCellera Biologics’ Stock is Going to Recover

    on SmarterAnalyst

    The 7 Best-Performing ETFs Money Can Buy In 2021

    on InvestorPlace.com

    BMO Capital Thinks AbCellera Biologics’ Stock is Going to Recover

    on SmarterAnalyst

    Stifel Nicolaus Thinks AbCellera Biologics’ Stock is Going to Recover

    on SmarterAnalyst

    AbCellera Biologics (ABCL) Gets a Buy Rating from Berenberg Bank

    on SmarterAnalyst

    AbCellera Biologics Inc.

    AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.